VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,033,275 | -12.8% | 38,397 | -2.5% | 0.08% | -11.6% |
| Q2 2023 | $1,185,503 | -24.7% | 39,372 | -19.1% | 0.10% | -28.6% |
| Q1 2023 | $1,574,337 | +120631.4% | 48,666 | +7.0% | 0.13% | +10.8% |
| Q4 2022 | $1,304 | -99.9% | 45,482 | +1.4% | 0.12% | +7.1% |
| Q3 2022 | $1,082,000 | -7.8% | 44,875 | +4.7% | 0.11% | +6.7% |
| Q2 2022 | $1,173,000 | +2.2% | 42,852 | +43.1% | 0.10% | +14.1% |
| Q1 2022 | $1,148,000 | +2.3% | 29,945 | -14.5% | 0.09% | 0.0% |
| Q4 2021 | $1,122,000 | +1.1% | 35,019 | -7.0% | 0.09% | -19.3% |
| Q3 2021 | $1,110,000 | -14.0% | 37,652 | -0.9% | 0.11% | -12.3% |
| Q2 2021 | $1,291,000 | +5.0% | 37,991 | +0.4% | 0.13% | +0.8% |
| Q1 2021 | $1,230,000 | +4.4% | 37,855 | +15.7% | 0.13% | -2.3% |
| Q4 2020 | $1,178,000 | +7.8% | 32,717 | +17.2% | 0.13% | -14.3% |
| Q3 2020 | $1,093,000 | – | 27,923 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |